Antiplatelet Therapy in Patients with Aneurysmal SAH: Impact on Delayed Cerebral Ischemia and Clinical Outcome. A Meta-Analysis.
Federico CagnazzoImad DerrazPierre-Henri LefevreGregory GascouCyril DargazanliCarlos RiquelmePaolo PerriniDavide Tiziano Di CarloAlain BonafeVincent CostalatPublished in: AJNR. American journal of neuroradiology (2019)
Overall, the incidence of delayed cerebral ischemia seems not to be significantly reduced among the antiplatelet therapy group. However, delayed cerebral ischemia tended to be lower among subjects with both long-term antiplatelet therapy and endovascular treatment and antiplatelet administration. Poor outcome and mortality rates were significantly reduced among the antiplatelet therapy group.